Search Within

Darren Richard Feldman

Formats
  1. Journal Article (189)
  2. Meeting Abstract (142)
  3. Book Section (6)
  4. Review (6)
  5. Guidelines (2)
  6. Research Letter (2)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Department of Medicine (349)
  2. Genitourinary Oncology Service (349)
  3. Solid Tumor Oncology Division (349)
  4. Survivorship Research (125)
  5. Surgery (114)
  6. Epidemiology and Biostatistics (112)

More Groups

People
  1. Robert Motzer (158)
  2. George Bosl (86)
  3. Martin Voss (81)
  4. Sujata Patil (81)
  5. Joel Sheinfeld (68)
  6. Chung-Han Lee (55)

More People

Years
  1. 2025 (16)
  2. 2024 (24)
  3. 2023 (20)
  4. 2022 (21)
  5. 2021 (25)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (148)
  2. Urology (13)
  3. Clinical Genitourinary Cancer (11)
  4. Cancer (10)
  5. Clinical Cancer Research (9)
  6. Investigational New Drugs (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (154)
  2. Elsevier Science, Inc. (29)
  3. Elsevier Inc. (28)
  4. Wiley Blackwell (20)
  5. Oxford University Press (18)
  6. American Association for Cancer Research (17)

More Publishers

Results (349)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Treatment outcome with mTOR inhibitors for 65 cases of non-clear cell renal cell carcinoma: Association of long-term responses and oncogenomic events
    Meeting Abstract

    Voss, M. H.; Bastos, D. A.; Karlo, C.; Patil, S.; Ajeti, A.; Hakimi, A. A.; Feldman, D. R.; Molina, A. M.; Berger, M. F.; Hsieh, J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term survival rates after chemotherapy (CTx) in patients (pts) with nonseminomatous (NS) germ cell tumors (GCT) with teratoma (T)
    Meeting Abstract

    Patil, S.; Feldman, D. R.; Bajorin, D. F.; Motzer, R. J.; Sheinfeld, J.; Tickoo, S.; Reuter, V. E.; Bosl, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of paclitaxel, ifosfamide, and cisplatin (TIP) for previously untreated patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • mTOR inhibitor therapy for metastatic sarcomatoid clear cell renal cell carcinoma (ccRCC)
    Meeting Abstract

    Bastos, D. A.; Voss, M. H.; Karlo, C.; Ajeti, A.; Patil, S.; Feldman, D. R.; Molina, A. M.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Antitumor activity of brentuximab vedotin in CD30 positive refractory germ cell tumors
    Meeting Abstract

    Albany, C.; Feldman, D. R.; Garbo, L. E.; Einhorn, L. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase I/II study of paclitaxel plus ifosfamide (TI) followed by high-dose paclitaxel, ifosfamide, and carboplatin (TIC) with autologous stem cell transplant (ASCT) for salvage treatment of germ cell tumors (GCT)
    Meeting Abstract

    Jia, X.; Feldman, D. R.; Glezerman, I.; Van Alstine, L. J.; Bajorin, D. F.; Fischer, P.; Hughes, A.; Sheinfeld, J.; Bains, M. S.; Reich, L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide, and cisplatin (TIP) efficacy for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)
    Meeting Abstract

    Feldman, D. R.; Hu, J.; Dorff, T. B.; Patil, S.; Van Alstine, L. J.; Momen, L.; Carousso, M.; Hughes, A.; Snively-Solomon, J.; Ketchens, C.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Targeted therapy for renal cell carcinoma (RCC) with brain metastasis: Overall survival (OS) and safety
    Meeting Abstract

    Bastos, D. A.; Molina, A. M.; Jia, X.; Velasco, S.; Patil, S.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to cisplatin and poly (ADP-ribose) polymerase inhibition
    Meeting Abstract

    Cavallo, F.; Graziani, G.; Antinozzi, C.; Feldman, D. R.; Houldsworth, J.; Bosl, G. J.; Chaganti, R. S. K.; Moynahan, M. E.; Jasin, M.; Barchi, M.
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Long-term response to sunitinib therapy for metastatic renal cell carcinoma
    Journal Article

    Molina, A. M.; Jia, X.; Feldman, D. R.; Hsieh, J. J.; Ginsberg, M. S.; Velasco, S.; Patil, S.; Motzer, R. J.
    Clinical Genitourinary Cancer (2013)

    Fulltext@MSK | Save